SCHEMBL29133704

SCHEMBL29133704

CC[C@]1(Nc2ncnc3ccc(-c4cncc(C(=O)OC)c4)cc23)C=CC=CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 10/20 0.54
▸ PIK3CD O00329 2/20 0.41
▸ PIK3CA P42336 2/20 0.41
▸ PIK3CB P42338 2/20 0.41
▸ EGFR P00533 1/20 0.41
▸ PIK3CG P48736 1/20 0.41
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ ALDH1A1 P00352 6/20 0.40
▸ HSD17B10 Q99714 5/20 0.40
▸ CYP3A4 P08684 5/20 0.40
▸ TSHR P16473 2/20 0.40
▸ CYP1A2 P05177 5/20 0.38
▸ CLK4 Q9HAZ1 4/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ USP2 O75604 3/20 0.38
▸ LMNA P02545 1/20 0.37
▸ HIF1A Q16665 1/20 0.37
▸ MAPK1 P28482 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133774 0.84 IRAK4 (0.47) IRAK4PIK3CAEGFRALDH1A1HSD17B10
SCHEMBL29133754 0.83 IRAK4 (0.51) IRAK4PIK3CDPIK3CAPIK3CBEGFR
SCHEMBL29133759 0.81 EGFR (0.57) PIK3CAEGFRALDH1A1HSD17B10CYP3A4
SCHEMBL29133711 0.81 PIK3CA (0.41) IRAK4PIK3CAEGFRHSD17B10CYP3A4
SCHEMBL29133732 0.80 PIK3CA (0.52) IRAK4PIK3CDPIK3CAPIK3CBEGFR
SCHEMBL29133728 0.79 IRAK4 (0.48) IRAK4EGFRALDH1A1HSD17B10CYP3A4
SCHEMBL29133716 0.78 IRAK4 (0.39) IRAK4EGFRALDH1A1HSD17B10CYP3A4
SCHEMBL29133742 0.77 IRAK4 (0.35) IRAK4PIK3CDPIK3CAALDH1A1HSD17B10
SCHEMBL29133739 0.75 HTT (0.50) IRAK4ALDH1A1CYP3A4TSHRCYP1A2
SCHEMBL29133745 0.75 HTT (0.50) IRAK4ALDH1A1CYP3A4TSHRCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 — — CN disclosed
Send feedback